Drugs / BAY987517
last change Jan 2017 re-read 3 minutes ago

BAY987517

also known as Y65-158
Investigated by
Bayer

Trials 19

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase not applicable19 trials
— NCT03002922 Jan 2017 — Bayer Completed No outcome recorded
— NCT03012347 Jan 2017 — Bayer Completed No outcome recorded
— NCT02995135 Jan 2017 — Bayer Completed No outcome recorded
— NCT02962869 Nov → Dec 2016 — Bayer Completed No outcome recorded
— NCT02962856 Nov 2016 — Bayer Completed No outcome recorded
— NCT02930785 Oct 2016 — Bayer Completed No outcome recorded
— NCT02877511 Aug 2016 — Bayer Completed No outcome recorded
— NCT02891057 Aug 2016 — Bayer Completed No outcome recorded
— NCT02891044 Aug → Sep 2016 — Bayer Completed No outcome recorded
— NCT02831478 Jul 2016 — Bayer Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 19 sources stand behind the page.

FieldValueCited text
Known as BAY987517 ClinicalTrials.gov intervention name — accepted as the source's own label NCT03012347 ↗
18

NCT02891044 ↗

NCT02815241 ↗

NCT02891057 ↗

NCT02930785 ↗

NCT02760563 ↗

NCT02842268 ↗

NCT02815202 ↗

NCT02822339 ↗

NCT02751372 ↗

NCT02831478 ↗

Show 8 more sources

Known as Y65-158 “Sunscreen formula Y65-158” NCT03002922 ↗
Route Topical “applied directly to two sites on the skin” NCT02750488 ↗